Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Clin Exp Dermatol ; 31(1): 60-2, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16309484

ABSTRACT

A 20-year-old Caribbean woman with sickle cell anaemia was admitted with a 4-day history of fever and a painful swollen right ankle. She rapidly developed skin necrosis. The differential diagnosis is discussed. This case illustrates the difficulty in identifying the cause of cutaneous necrosis in an acutely ill patient. In our patient, histopathology implicated a vasculitic process, which was subsequently identified as a manifestation of microscopic polyarteritis.


Subject(s)
Anemia, Sickle Cell/complications , Polyarteritis Nodosa/diagnosis , Skin/pathology , Adult , Anemia, Sickle Cell/pathology , Breast/pathology , Diagnosis, Differential , Female , Hand/blood supply , Hand/pathology , Humans , Necrosis , Polyarteritis Nodosa/complications , Polyarteritis Nodosa/therapy , Treatment Outcome
2.
Clin Exp Dermatol ; 27(8): 680-3, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12472546

ABSTRACT

Congenital erythropoietic porphyria is a rare autosomal recessive disorder of haem biosynthesis caused by a deficiency of uroporphyrinogen III synthetase. There is resultant accumulation and hyperexcretion of porphyrinogens of the isomer I variety. These are converted by spontaneous oxidation into their corresponding photoactive porphyrins leading to photodamage. Accumulation of porphyrins results in haemolysis and extensive photosensitivity. The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation. We present a 35-year-old man who has the severe infantile form and illustrates the haematological and photodestructive complications despite attempts at treatment with hypertransfusion, oral charcoal therapy and beta-carotene. Allogenic bone marrow transplantation has been considered but because of the high associated mortality this procedure has been discounted at present in the management of our patient.


Subject(s)
Porphyria, Erythropoietic/therapy , Adult , Anemia, Hemolytic/etiology , Anemia, Hemolytic/therapy , Blood Transfusion , Bone Diseases/etiology , Deferoxamine/administration & dosage , Female , Hematopoietic Stem Cell Transplantation/methods , Humans , Iron Chelating Agents/administration & dosage , Iron Overload/drug therapy , Iron Overload/etiology , Porphyria, Erythropoietic/complications
SELECTION OF CITATIONS
SEARCH DETAIL